Scott Mendel - Oct 2, 2024 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Scott Mendel, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Oct 2, 2024
Transactions value $
$0
Form type
4
Date filed
10/4/2024, 06:44 PM
Previous filing
Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKYA Stock Option (right to buy) Award $0 +45K $0.00 45K Oct 2, 2024 Common Stock 45K $2.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continuous service through the vesting dates, the options shall vest ratably on a quarterly basis over four quarters, with the first vesting date to occur on January 1, 2025.